Our findings indicated that inhibition of JNK in pancreatic CSLCs resulted in decreased stem cell marker expression and sphere-forming ability, as well as in loss of their tumor-initiating capacity, thus identifying JNK as a hitherto unrecognized, novel key player in the control of pancreatic CSCs/CSLCs. This evidence concerns the gene MAPK8 and neoplasm.